Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00054873 · ClinicalTrials.gov registry record · Phase 2
Tezacitabine With or Without 5-Fluorouracil (5-FU) for Advanced Esophageal Cancer or Gastric Cancer
A Phase 2 study, sponsored by Chiron Corporation.
- Completed
- Registry status
- Phase 2
- Development phase
NCT00054873 is a Phase 2 study that has completed, run by Chiron Corporation.
The verdict
NCT00054873, a Phase 2 study, has completed, sponsored by Chiron Corporation.
- COMPLETED
- Registry status
- Phase 2
- Development phase
Study Summary
The purpose of this study is to evaluate the efficacy and safety of tezacitabine when given alone or in combination with 5-fluorouracil (5-FU) to subjects who have advanced esophageal or gastric adenocarcinoma.
Interventions
- DRUG 5-fluorouracil
- DRUG tezacitabine
Trial Details
| Field | Value |
|---|---|
| Start Date | 2003-11 |
| Est. Completion | 2004-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00054873
The ClinicalTrials.gov registry entry for NCT00054873 describes a study currently listed as completed, categorized as Phase 2. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Chiron Corporation, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which 5-fluorouracil is the first listed.
NCT00054873 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00054873 about?
NCT00054873 is a clinical study titled "Tezacitabine With or Without 5-Fluorouracil (5-FU) for Advanced Esophageal Cancer or Gastric Cancer". The purpose of this study is to evaluate the efficacy and safety of tezacitabine when given alone or in combination with 5-fluorouracil (5-FU) to subjects who have advanced esophageal or gastric adenocarcinoma.
What is the current status of trial NCT00054873?
This trial is currently completed. It is a Phase 2 study. The study started on 2003-11. Estimated completion is 2004-12.
What interventions are being tested in trial NCT00054873?
The interventions under investigation include: 5-fluorouracil (DRUG), tezacitabine (DRUG).
Who is sponsoring clinical trial NCT00054873?
This trial is sponsored by Chiron Corporation, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.